These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 4406898)

  • 1. Standardization of drug names.
    Allan FM
    JAMA; 1974 Jul; 229(5):541-3. PubMed ID: 4406898
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Standardization of drug names.
    Lewis JR
    JAMA; 1974 Jul; 229(5):559-60. PubMed ID: 4406902
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Standardization of drug names--a commentary.
    Lee A
    JAMA; 1974 Jul; 229(5):560-2. PubMed ID: 4406903
    [No Abstract]   [Full Text] [Related]  

  • 4. Generic nomenclature.
    Wells BB
    JAMA; 1974 Jul; 229(5):527. PubMed ID: 4406896
    [No Abstract]   [Full Text] [Related]  

  • 5. The USAN nomenclature system.
    Jerome JB; Sagon P
    JAMA; 1975 Apr; 232(3):294-9. PubMed ID: 1173125
    [No Abstract]   [Full Text] [Related]  

  • 6. Generic acrimony.
    Dunea G
    Br Med J; 1979 Jul; 2(6181):31-2. PubMed ID: 466259
    [No Abstract]   [Full Text] [Related]  

  • 7. Plugs for drugs.
    Masson A; Rubin PH
    Regulation; 1986; 10(1):37-43, 53. PubMed ID: 10280556
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug names--a semblance of order.
    Feldman EG
    J Pharm Sci; 1966 Jun; 55(6):i. PubMed ID: 5924136
    [No Abstract]   [Full Text] [Related]  

  • 9. Doctors are pivotal to prescription struggle.
    Chapman S
    Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688
    [No Abstract]   [Full Text] [Related]  

  • 10. International reporting on adverse drug reactions: the CIOMS project. CIOMS ADR Working Group.
    Faich GA; Castle W; Bankowski Z
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):133-8. PubMed ID: 2338366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Customary and usual brand names.
    Sperber E
    N Engl J Med; 1969 Feb; 280(8):450. PubMed ID: 5763098
    [No Abstract]   [Full Text] [Related]  

  • 12. The selection and protection of international nonproprietary names for pharmaceutical substances.
    Wehrli A
    WHO Chron; 1981; 35(5):172-5. PubMed ID: 7324459
    [No Abstract]   [Full Text] [Related]  

  • 13. Labeling regulations: 'prescribe as directed'.
    Regier H
    J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706
    [No Abstract]   [Full Text] [Related]  

  • 14. Lawsuits anticipated on generic biologicals front.
    Fox JL
    Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
    [No Abstract]   [Full Text] [Related]  

  • 15. How do drugs get their brand names?
    Novack GD
    Ocul Surf; 2012 Apr; 10(2):117-20. PubMed ID: 22482472
    [No Abstract]   [Full Text] [Related]  

  • 16. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2013; (981):i-xi, 1-188. PubMed ID: 23821930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar drug names a risky prescription.
    Hampton T
    JAMA; 2004 Apr; 291(16):1948-9. PubMed ID: 15113794
    [No Abstract]   [Full Text] [Related]  

  • 18. The learned intermediary doctrine: past, present and future.
    Alsobrook HB
    Leg Med; 1994; ():269-80. PubMed ID: 7830482
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes to drug names.
    Loe B
    Nurs N Z; 2008 Mar; 14(3):3-4. PubMed ID: 18494130
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of orphan products.
    FDA Drug Bull; 1983 Apr; 13(1):2-4. PubMed ID: 6852406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.